Adenocarcinoma of the uterine cervix.
From January 1, 1947, through December 31, 1971, 219 patients with primary adenocarcinoma of the intact uterine cervix were treated at the M.D. Anderson Hospital and Tumor Institute.  Two modes of therapy were primarily used, namely, irradiationtherapy alone and irradiation therapy plus operation.  The 5 year survival resultsare 83.7 per cent for patients with Stage i disease, 48.0 per cent for patients with Stage ii disease, 29.2 per cent for patients with Stage iii disease, and 0.0 per cent for patients with Stage iv disease.  The group with irradiation plus operation had a better over-all survival rate.  In addition, the incidence of central and pelvic recurrent disease was remarkably lower (fourfold difference).  The urologic and bowel complications are discussed.  This review lends support for our practice of preoperative irradiation followed by simple (constructive) hysterectomy for selected patients eith adenocarcinoma of the uterine cervix.
D000230:Adenocarcinoma / Q000532:radiotherapy / Q000601:surgery; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D044466:Asian People; D044383:Black People; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010298:Parity; D011879:Radiotherapy Dosage; D013997:Time Factors; D002583:Uterine Cervical Neoplasms / Q000532:radiotherapy / Q000601:surgery; D044465:White People